'Nih guidelines' diaporamas de présentation

NIH Office of Biotechnology Activities

NIH Office of Biotechnology Activities. Within the Office of Science Policy, Office of the Director, NIH Five programs: Recombinant DNA (RAC) Genetics (SACGHS) Xenotransplantation (SACX) Biosecurity (NSABB) Outreach and Education. Recombinant DNA Program.

1.28k views • 103 slides

Chapter 8: Recombinant DNA Technology and Molecular Cloning

Chapter 8: Recombinant DNA Technology and Molecular Cloning.

1.52k views • 101 slides

NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules

Overview of the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.

693 views • 56 slides

NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules

Overview of the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.

569 views • 56 slides

CONTROLLING CHEMICAL and BIOHAZARDS ASSOCIATED WITH BT-WMD INCIDENTS

CONTROLLING CHEMICAL and BIOHAZARDS ASSOCIATED WITH BT-WMD INCIDENTS. Philip G. Hauck, MS, MSHS CIH, SM(NRM). 6/2005. Controlling Microbial Hazards.

704 views • 53 slides

767 views • 51 slides

Biological Laboratory Safety University of Colorado at Boulder

Biological Laboratory Safety University of Colorado at Boulder. UNIVERSITY OF COLORADO AT BOULDER. Environmental Health and Safety www.colorado.edu/ehs (303) 492-6025 ehsbio@colorado.edu. Introduction. Biological Laboratory Safety Training.

897 views • 47 slides

Title

Title. Title. Biodefense research: oversight of safety, oversight of security, and oversight of dual-use implications. Richard H. Ebright Howard Hughes Medical Institute, Waksman Institute, Department of Chemistry Rutgers University. safety-background.

607 views • 41 slides

Stem Cell Research Fact vs. Friction

527 views • 38 slides

Introduction

Introduction.

405 views • 35 slides

Introduction

Introduction.

411 views • 35 slides

Key Definitions and Acronyms

Overview of the Roles, Responsibilities and Interactions of the Principal Investigator with the MSSM Institutional Biosafety Committee (IBC) pgh/ 10/2004. Key Definitions and Acronyms. Biosafety Level (BL) :

502 views • 34 slides

Overview of the NIH Guidelines for Research Involving Recombinant DNA Molecules

Overview of the NIH Guidelines for Research Involving Recombinant DNA Molecules. What are the NIH Guidelines for Research Involving Recombinant DNA Molecules ?. These guidelines specify practices for constructing and handling : Recombinant DNA (rDNA) molecules

485 views • 32 slides

Teleconference August 5, 2008

NIH Blue Ribbon Panel on Risk Assessment of the BUMC National Emerging Infectious Diseases Laboratories. Teleconference August 5, 2008. Topics. Work Plan Update re Risk Assessment studies Community Engagement Plan Boston municipal prohibition on use of rDNA in BSL-4 lab. Risk

302 views • 24 slides

MTAs: An Overview

MTAs: An Overview. Lakita Cavin, J.D., Ph.D. Staff Attorney University of Tennessee Research Foundation. What is an MTA?. Most material exchanges require MTA that must have an institutional signature. Contract Any exchange of promises is a contract License agreement

360 views • 23 slides

Outline

Outline. Introduction to the National Institutes of Health Office of Biotechnology Activities History and Evolution of IBCs: Asilomar to the Present Overview of the Current NIH Guidelines for Research Involving Recombinant DNA Molecules Requirements for IBCs in the NIH Guidelines

280 views • 21 slides

IACUC and IBC PROCESS

324 views • 12 slides

ADS 211: Biosafety Procedures for Genetic Engineering Research

ADS 211: Biosafety Procedures for Genetic Engineering Research. Draft USAID Guidance. Activities Covered. Transferring genetically engineered products to a developing country for release outside a contained facility Field testing livestock vaccines in a LDC

169 views • 6 slides